The Sustainable Development Goal 3 (SGD-3) aspires to ensure health and well-being for all with all countries aiming to reduce neonatal mortality end and end preventable deaths of newborns and children under 5 years of age by 2030. Congenital anomalies cause death and disability, as well as affect families and communities throughout the lifespan. Meeting this challenge effectively requires addressing both its roots and the branches — the causes as well as the outcomes of congenital anomalies. Triple surveillance and triple action provide a framework to concurrently understand and address risk factors, occurrence, and health outcomes.

This webinar will focus on:
1. An update of the burden and causes of congenital anomalies and their contribution to child mortality.
2. Current programs for newborn care that include prevention and care for CA.
3. The benefits of Triple surveillance with the overall goal to prevent what can be prevented and treat optimally what cannot.

Chair:
Professor Philippa Musoke, Executive Director, Makerere University – Johns Hopkins University Research Collaboration, PI of Hospital-based Birth Defect Surveillance Program in Kampala, Uganda
Speakers:
Dr Ornella Lincetto, Senior Medical Officer Newborn Health, Department of Maternal, Newborn, Child and Adolescent Health, World Health Organization, Geneva Switzerland
Dr Lorenzo Botto, Professor of Pediatrics and Medical Genetics, University of Utah School of Medicine; Executive Committee Member of International Clearinghouse for Birth Defect Surveillance and Research